Morning Overview on MSN
A year of added prostate-cancer therapy cut the odds the disease spreads, a major trial found
Men treated for prostate cancer after surgery now have clearer evidence that extending hormone therapy from six months to two ...
The MarketWatch News Department was not involved in the creation of this content. EDMONTON, AB, April 20, 2026 /PRNewswire/ - Nanostics Inc., a precision health company advancing diagnostic innovation ...
Stereotactic ablative radiotherapy for prostate cancer treatment has been proven effective at five doses versus 20 with ...
Daniel W. Lin, MD, reviews new guidance on using MRI, biomarkers, and more, to improve the detection of prostate cancer.
New guidance set to land within weeks could open PSA testing to any Australian man who wants it, as survivors and specialists ...
When high-profile figures publicly discuss their prostate cancer, the public health impact can be immediate. The media ...
If your cancer is not causing any symptoms, is growing slowly, or is small and only in your prostate, your physician may suggest active surveillance or watchful waiting instead of treatment. Active ...
Millions of men face a decision about whether to be screened for prostate cancer. National guidelines say that decision ...
The MarketWatch News Department was not involved in the creation of this content. EDMONTON, AB, April 20, 2026 /CNW/ - Nanostics Inc., a precision health company advancing diagnostic innovation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results